Cargando…
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
BACKGROUND: We examined the longitudinal associations between changes in cardiovascular biomarkers and cancer therapy–related cardiac dysfunction (CTRCD) in patients with breast cancer treated with cardotoxic cancer therapy. METHODS AND RESULTS: Repeated measures of high‐sensitivity cardiac troponin...
Autores principales: | Demissei, Biniyam G., Hubbard, Rebecca A., Zhang, Liyong, Smith, Amanda M., Sheline, Karyn, McDonald, Caitlin, Narayan, Vivek, Domchek, Susan M., DeMichele, Angela, Shah, Payal, Clark, Amy S., Fox, Kevin, Matro, Jennifer, Bradbury, Angela R., Knollman, Hayley, Getz, Kelly D., Armenian, Saro H., Januzzi, James L., Tang, W. H. Wilson, Liu, Peter, Ky, Bonnie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033834/ https://www.ncbi.nlm.nih.gov/pubmed/31959034 http://dx.doi.org/10.1161/JAHA.119.014708 |
Ejemplares similares
-
Primer on Biomarker Discovery in Cardio-Oncology: Application of Omics Technologies
por: Rhee, June-Wha, et al.
Publicado: (2020) -
Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab
por: Demissei, Biniyam G., et al.
Publicado: (2020) -
Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2‐Year Postchemotherapy Measures of Left Ventricular Ejection Fraction
por: Suerken, Cynthia K., et al.
Publicado: (2020) -
Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022) -
BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors
por: Demissei, Biniyam G., et al.
Publicado: (2022)